Table 1.

Demographic and clinical characteristics of the patients of the study treated with tigecycline.

	Gender (M: Male, F: Female)	Age (Years)	BMI (kg/m2)	FEV1 %on Admission	FVC% on Admission	Exacerbations/ Past Year	CRP (mg/dL) on Admission	WBC (Cells/mm3) on Admission
Patient 1	F	60	46.0	51	51	0	7.4	7400
Patient 2	M	73	32.8	28	51	0	3.5	7600
Patient 3	F	51	34.6	39	60	0	4.2	5700
Patient 4	F	77	37.6	54	66	1	3.6	7400
Patient 5	M	79	31.3	24	53	1	3.2	11,500
Patient 6	F	53	49.3	37	49	2	4.9	9440
Patient 7	M	82	30.8	44	68	1	13.5	16,700
Patient 8	M	60	37.0	59	59	0	6.0	11,100
Patient 9	M	88	30.0	61	71	0	6.9	6100
Patient 10	F	62	25.8	41	60	0	11.2	4300
Patient 11	M	74	24.2	37	40	1	4.5	6000
Mean ± SD	5F/6M	69 ± 12	34.4 ± 7.4	43.18 ± 11.45	57.09 ± 8.84	0.54	6.25 ± 3.18	8476 ± 3365